Oncopeptides AB

Stocks

Real-time Estimate Cboe Europe 17:37:06 29/10/2026 +04			5-day change	1st Jan Change
1.711 ^SEK	+3.07%		+2.59%	-64.60%

10-15	Two Sigma Investments becomes a new public short seller in Oncopeptides	FW
10-14	Mixed close on Stockholm exchange, SEB fell on higher capital requirements	FW

Published on 10/12/2026 at 11:51 am +04 - Modified on 10/12/2026 at 02:05 pm +04

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Welcome to Oncopeptides Investor Update, October 2026. [Operator Instructions] Now I will hand the conference over to CEO, Sofia Heigis; and CFO,

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

10-15	Two Sigma Investments becomes a new public short seller in Oncopeptides	FW
10-14	Mixed close on Stockholm exchange, SEB fell on higher capital requirements	FW
10-14	Stockholm exchange edges higher ahead of US CPI, SEB plunges	FW
10-14	SEB falls on mixed Stockholm exchange, OMXS30 index up 0.1 percent	FW
10-14	Stockholm exchange expected to open Wednesday with a slight gain	FW
10-14	Oncopeptides Completes Directed Share Issue Of SEK 100 Mln	RE
10-14	Oncopeptides raises SEK100m in directed share issue	FW
10-13	Oncopeptides plans directed share issue of SEK100m	FW
10-12	Redeye maintains fair value for Oncopeptides after positive study data	FW
10-12	Oncopeptides AB - Special Call
10-09	Oncopeptides reports positive early data from brain cancer study	FW
10-09	Oncopeptides confirms passage into brain tumor in glioblastoma study	FW
10-09	Oncopeptides AB Confirms Blood-Brain-Barrier Penetration Based on Data from First Patients in Glioblastoma Window-Of-Opportunity Study	CI
09-22	Oncopeptides to present preclinical and translational glioblastoma data at conference	FW
09-22	Oncopeptides AB Announces Preclinical And Translational Glioblastoma Data On Next-Generation Alkylating Peptide-Drug Conjugates To Be Presented At EANO 2026	CI